The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia

被引：10
|
作者：
Chen, Xiaojun [1 ,2 ]
机构：
[1] Fudan Univ, Dept Gynecol, Obstet & Gynecol Hosp, 419 Fangxie Rd, Shanghai 200011, Peoples R China
[2] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China
来源：
JOURNAL OF GYNECOLOGIC ONCOLOGY | 2019年 / 30卷 / 04期
关键词：
MANAGEMENT; WOMEN;
D O I：
10.3802/jgo.2019.30.e79
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] LNG-IUS combined with progesterone ameliorates endometrial thickness and pregnancy outcomes of patients with early-stage endometrial cancer or atypical hyperplasia
    Fang, Fang
    Xu, Hao
    Wu, Ling
    Hu, Linyi
    Liu, Ying
    Li, Yinnan
    Zhang, Chunhua
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (05): : 5412 - 5419
  • [2] Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma
    Giannopoulos, T
    Butler-Manuel, S
    Tailor, A
    GYNECOLOGIC ONCOLOGY, 2004, 95 (03) : 762 - 764
  • [3] Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women
    Morelli, Michele
    Di Cello, Annalisa
    Venturella, Roberta
    Mocciaro, Rita
    D'Alessandro, Pietro
    Zullo, Fulvio
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (02) : 156 - 159
  • [4] The levonorgestrel intrauterine system (LNG-IUS) for prevention of endometrial cancer in women with obesity is cost effective
    Bernard, Laurence
    Kwon, Janice
    Simpson, Andrea
    Ferguson, Sarah
    Sinasac, Sarah
    Pina, Annick
    Reade, Clare
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S300 - S301
  • [5] Efficacy of the LNG-IUS for treatment of endometrial hyperplasia and early stage endometrial cancer: Can biomarkers predict response?
    Dore, Molly
    Filoche, Sara
    Danielson, Kirsty
    Henry, Claire
    GYNECOLOGIC ONCOLOGY REPORTS, 2021, 36
  • [6] The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia - A long-term follow-up study
    Varma, Rajesh
    Soneja, Hemi
    Bhatia, Kalsang
    Ganesan, Raji
    Rollason, Terence
    Clark, T. Justin
    Gupta, Janesh K.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2008, 139 (02) : 169 - 175
  • [7] Combined oral medroxyprogesterone (MPA)/levonorgestrel-intrauterine system (LNG-IUS) treatment for women with grade 2 stage IA endometrial cancer of grade 2
    Kim, M. K.
    Young, H. Ji
    Hee, K. Da
    Sook, H. A. K. Hyo
    Mi-La, K.
    Wook, J. Yong
    Seong, Y. Bo
    Ju, S. Seok
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 1005 - 1005
  • [8] Levonorgestril Intrauterine System (LNG-IUS) Versus Medroxyprogesterone Acetate for the Treatment of Endometrial Hyperplasia: A Randomized Control Trial
    Rizvi, Sarwat
    Ghaffar, Shanza
    Haider, Rubar
    Jafri, Anum
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2018, 12 (02): : 675 - 678
  • [9] Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study
    Scarselli, Gianfranco
    Bargelli, Gianni
    Taddei, Gian Luigi
    Marchionni, Mauro
    Peruzzi, Elena
    Pieralli, Annalisa
    Mattei, Alberto
    Buccoliero, Anna Maria
    Fambrini, Massimiliano
    FERTILITY AND STERILITY, 2011, 95 (01) : 420 - 422
  • [10] Comparison between the levonorgestrel intrauterine system (LNG-IUS) and thermal balloon ablation in the treatment of menorrhagia
    Barrington, JW
    Arunkalaivanan, AS
    Abdel-Fattah, M
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2003, 108 (01) : 72 - 74
12345